Home genetic test maker 23andMe, which is backed by Google Inc, stopped marketing its products last week after the U.S. Food and Drug Administration warned that it did not have regulatory approval to do so, a company spokeswoman said. The company stopped television, radio and online advertising for its $99 DNA test which is supposed to detect a range of genetic variants and provide information about a person's health risks, the spokeswoman said. The FDA said last week it had sent a warning letter to the company on Nov. 22 stating that products designed to diagnose, mitigate or prevent disease were medical devices that required regulatory clearance.
Help employers find you! Check out all the jobs and post your resume.
